Dexcom Beats First-Quarter Expectations, But Shares Tumble

Dexcom stock tumbled late Thursday after the diabetes devices company reported adjusted earnings of 33 cents per share on $505 million in sales for its first quarter.


On average, analysts polled by FactSet expected Dexcom (DXCM) to earn 30 cents per share on $483.9 million in sales.

In the year-earlier period, Dexcom earnings were 44 cents per share on $405.1 million in sales.

For the year, Dexcom guided to $2.26 billion to $2.36 billion in sales. Analysts called for Dexcom earnings of $2.32 per share on $2.32 billion in sales.

In after-hours trading on the stock market today, Dexcom stock tripped 4% near 405. Dexcom stock is consolidating with a buy point at 456.33, according to

More to follow.

Follow Allison Gatlin on Twitter at @IBD_AGatlin.


Merck Stock Dives As Pandemic Bungles First-Quarter Sales, Earnings

Bristol Myers Disappoints In First Quarter, But Retains Its Full-Year Guidance

Want To Get Quick Profits And Avoid Big Losses? Try SwingTrader

Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks

Looking For The Next Big Stock Market Winners? Start With These 3 Steps

Most Related Links :
usnewsmail Governmental News Finance News

Source link

Back to top button